BIO BLAST PHARMA LTD's ticker is ORPN and the CUSIP is M20156101. A total of 11 filers reported holding BIO BLAST PHARMA LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2015 | $5,000 | -28.6% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 250,970 | $625,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 1,133,937 | $2,824,000 | 0.14% |
| Visium Asset Management, LP | 713,625 | $1,777,000 | 0.03% |
| OPPENHEIMER & CO INC | 62,465 | $155,000 | 0.01% |
| Virtu KCG Holdings LLC | 21,771 | $54,000 | 0.00% |
| UBS Group AG | 1,698 | $4,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,000 | $2,000 | 0.00% |
| MORGAN STANLEY | 25 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 242 | $1,000 | 0.00% |
| HighTower Advisors, LLC | 35,700 | $86,000 | 0.00% |